Cargando…

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study

BACKGROUND: Oesophageal (OeC) and gastric (GC) cancer patients are treated with similar multimodal therapy and have poor survival. There remains an urgent clinical need to identify biomarkers to individualise patient management and improve outcomes. Therapy with immune checkpoint inhibitors has show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hewitt, L.C., Inam, I.Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G.E., Melotte, V., Langley, R.E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G.G., Grabsch, H.I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914544/ https://www.ncbi.nlm.nih.gov/pubmed/29550565 http://dx.doi.org/10.1016/j.ejca.2018.02.014

Ejemplares similares

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial
por: Davarzani, Nasser, et al.
Publicado: (2018)

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
por: Hale, Matthew D., et al.
Publicado: (2016)

Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Silva, Arnaldo N. S., et al.
Publicado: (2022)

Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
por: Silva, Arnaldo N S, et al.
Publicado: (2022)

Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction
por: Allum, W. H., et al.
Publicado: (2019)

Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial
por: Kloft, Maximilian, et al.
Publicado: (2023)

Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides
por: Beuque, Manon, et al.
Publicado: (2023)

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
por: Alderson, Derek, et al.
Publicado: (2017)

Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer
por: Kerckhoffs, K. G. P., et al.
Publicado: (2020)

Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
por: Muti, Hannah Sophie, et al.
Publicado: (2021)

Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma
por: Plum, Patrick Sven, et al.
Publicado: (2019)

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
por: Obulkasim, Askar, et al.
Publicado: (2016)

Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer
por: Miyazono, F, et al.
Publicado: (2004)

KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study
por: Hewitt, Lindsay C., et al.
Publicado: (2019)

Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials
por: Athauda, Avani, et al.
Publicado: (2023)

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2014)

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
por: Smyth, Elizabeth C., et al.
Publicado: (2016)

Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fields
por: Koemans, Willem J., et al.
Publicado: (2020)

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2015)

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2016)

Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
por: von Loga, Katharina, et al.
Publicado: (2020)

Epidemiological features of gastric and oesophageal cancers in Slovakia.
por: Macfarlane, G. J., et al.
Publicado: (1994)

Severe ulcerative oesophagitis caused by primary Epstein-Barr virus infection in an immunocompetent individual
por: Lorentsen, Ruben Due, et al.
Publicado: (2021)

Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence
por: Pasternack, Helen, et al.
Publicado: (2018)

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study
por: van Grieken, N C T, et al.
Publicado: (2013)

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study
por: van Grieken, N C T, et al.
Publicado: (2014)

The Cumulative Effects of Polymorphisms in the DNA Mismatch Repair Genes and Tobacco Smoking in Oesophageal Cancer Risk
por: Vogelsang, Matjaz, et al.
Publicado: (2012)

Ethnicity in relation to incidence of oesophageal and gastric cancer in England
por: Coupland, V H, et al.
Publicado: (2012)

Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
por: Draht, Muriel X. G., et al.
Publicado: (2018)

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
por: Starling, N, et al.
Publicado: (2009)

Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
por: von Loga, Katharina, et al.
Publicado: (2020)

Œsophageal Stricture
por: Painter, E. T.
Publicado: (1888)

T-tube placement as a method for treating penetrating oesophageal injuries
por: Gill, Roger Christopher, et al.
Publicado: (2016)

Somatostatin for Bleeding Oesophagitis or Ulceration After Sclerotherapy for Oesophageal Varices
por: Hobbs, K. E. F.
Publicado: (1992)

Factors associated with oesophageal cancer in Soweto, South Africa.
por: Segal, I., et al.
Publicado: (1988)

Systematic review of the introduction and evaluation of magnetic augmentation of the lower oesophageal sphincter for gastro‐oesophageal reflux disease
por: Kirkham, E. N., et al.
Publicado: (2019)

The multi-disciplinary management of complex congenital and acquired tracheo-oesophageal fistulae
por: Thakkar, H. S., et al.
Publicado: (2018)

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
por: West, N P, et al.
Publicado: (2010)

Oesophageal Stents for Potentially Curable Oesophageal Cancer – A Bridge to Surgery?
por: Tham, Jennifer E, et al.
Publicado: (2019)

Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis
por: Vicario, M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0ou1u2erupsch4r1gtssbne0au